Cerebrocellular swelling in the presence of uraemic guanidino compounds: Ameliorative effects of taurine

Neurochemical Research

Volumn 30, Issue 12, 2005, Pages 1465-1470

  Law, R O ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Cell volume; Cerebrocortical slices; Guanidino compounds; Oxidative nitrosative stress; Taurine

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ACETYLCYSTEINE; ANTIOXIDANT; ASCORBIC ACID; BICUCULLINE; BUTYLCRESOL; ENZYME INHIBITOR; GUANIDINE; GUANIDINE DERIVATIVE; GUANIDINOSUCCINIC ACID; GUANIDOETHYLSULFONIC ACID; LIPID PEROXIDASE; NORTIRILAZAD; PROTEIN INHIBITOR; TAURINE; TAURINE TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN EDEMA; CELL SWELLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; REMISSION; STATISTICAL SIGNIFICANCE;

ANIMALS; BRAIN EDEMA; GUANIDINE; MALE; NEUROPROTECTIVE AGENTS; NITROSATION; OXIDATIVE STRESS; RATS; RATS, WISTAR; TAURINE;

ANIMALIA;

EID: 29144439709     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-005-8823-y     Document Type: Article

References (46)

1. S. M. Moe S. M. Sprague 1994 Uremic encephalopathy Clin. Nephrol. 42 251 256
2. C. L. Fraser A. L. Arieff 1988 Nervous system complications in uremia Annals Int Med. 109 143 153
3. P. P. De Deyn V. K. Saxena H. Abts F. Borggreve R. D'Hooge B. Marescau R. Crols 1992 Clinical and pathophysiological aspects of neurological complications in renal failure Acta Neurol. Belg. 92 191 206
4. W. H. Horl 1998 Genesis of the uraemic syndrome: Role of uremic toxins Weiner Klin. Wochen. 110 511 520
5. R. Vanholder 2001 Uremic toxicity: Present state of the art Int. J. Artif. Organs. 24 695 725
6. R. C. Vanholder G. Glorieux R. De Smet P. P. De Deyn 2003 Low water-soluble uremic toxins Adv. Renal Repl. Therap. 10 257 269
7. R Vanholder 2003 Review on uremic toxins: Classification, concentration, and interindividual variability Kidney Int. 63 1934 1943
8. R. Vanholder R. De Smet 1999 Pathophysiologic effects of uremic retention solutes J. Am. Soc. Nephrol. 10 1815 1823
9. T. Boure R. Vanholder 2004 Biochemical and clinical evidence for uremic toxicity Artif. Org. 28 248 253
10. P. P. De Deyn R. L. Macdonald 1990 Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses in mouse neurons in cell culture Ann. Neurol. 28 627 633
11. A. Tanaka Y. Takahashi M. Mizokuchi M. Shimda H. Koide 1999 Plasma, urinary and electrolyte concentrations of guanidine compounds in patients with chronic renal failure Renal Failure 21 499 514
12. 2+ channels in the neuroexcitatory and synergistic effects of putative uremic toxins Kidney Int. 63 1764 1775
13. P. P. De Deyn P. Robitaille M. Vanasse I. A. Qureshi B. Marescau 1995 Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis Nephron 69 411 417
14. De Deyn, P. P., Marescau, B., D'Hooge, R., Possemiers, I., Nagler, J., and Mahler, C., 1997. Guanidino compound patterns in uraemic brain. Pages 279-288. in De Deyn, P. P., Marescau, B., Qureshi, I. A., and Mori A. (eds.), Guanidino Compounds:2. John Libbey & Co Ltd
15. P. P. De Deyn R. D'Hooge P.-P. Van Bogaert B. Marescau 2001 Endogenous guanidine compounds as uremic neurotoxins Kidney Int. 59 Suppl. 78 S77 S83
16. P. P. De Deyn R. Vanholder R. D'Hooge 2003 Nitric oxide in uremia: Effects of several potentially toxic guanidino compounds Kidney Int. 63 Suppl. 84), S25 S28
17. H. Pasantes-Morales A. Schousboe 1997 Role of taurine in osmoregulation in brain cells: Mechanisms and functional implications Amino Acids 12 281 292
18. H. Hagberg A. Lehmann M. Sandberg B. Nystrom I. A. Jacobson And Hamberger 1985 Ischemic-induced shifts of inhibitory and excitatory amino acids in area CA1 of the rat hippocampus Dev. Brain Res. 38 286 290
19. P. Saransaari S. S. Oja 1998 Mechanisms of ischaemia-induced taurine release in mouse hippocampal slices Brain Res. 807 118 124
20. P. Saransaari S. S. Oja 1998 Release of endogenous glutamate, aspartate, GABA, and taurine from hippocampal slices from adult and developing mice under cell-damaging conditions Neurochem. Res. 23 563 570
21. P. Saransaari S. S. Oja 1999 Characteristics of ischaemia-induced taurine release in the developing mouse hippocampus Neuroscience 94 949 954
22. S. Molchanova P. Koobi S. S. Oja P. Saransaari 2004 Interstitial concentrations of amino acids in the rat striatum during global forebrain ischaemia and potassium evoked spreading depression Neurochem. Res. 29 1519 1527
23. P. Saransaari S. Oja 2000 Taurine and neural cell damage Amino Acids 19 509 526
24. S. W. Schaffer J. Azuma J. D. Madura 1995 Mechanisms underlying taurine-mediated alterations in membrane function Amino Acids 8 231 246
25. S. Schaffer J. Azuma K. Takahashi M. Mozaffari 2003 Why is taurine neuroprotective? Adv. Exp. Med. Biol. 526 307 321
26. J. Himmelfarb R. M. Kakim 2003 Oxidative stress in uremia Current Opin. Nephrol. Hyperten. 12 593 598
27. N. D. Vaziri 2003 Oxidative stress in chronic renal failure: Lessons learned from the animal models Blood Purif. 21 328 330
28. J. Galle S. Seibold. 2003 Has the time come to use antioxidant therapy in uraemic patients? NephrolDial. Transplant. 18 1452 1455
29. M. Prakash S. Upadhya R. Prabhu 2004 Protein thiol oxidation and lipid peroxidation in patients with uraemia Scand. J. Clin. Lab. Invest. 64 599 604
30. Law, R. O. 2005. Taurine protects against the neurotoxic effects of guanidino compounds. Amino Acids. 29:15
31. R. O. Law 1994 Taurine efflux and the regulation of cell volume in incubated slices of rat cerebral cortex Biochim. Biophys. Acta 1221 21 28
32. R. O. Law 1988 An inwardly-directed sodium-amino acid cotransporter influences steady-state cell volume in slices of rat renal papilla Incubated in hyperosmotic media Pflug. Arch. 413 43 50
33. R. J. [tmp] MacAllister M. H. Rambausek P. Vallence D. Williams K. H. Hoffmann E. Ritz 1996 Concentration of dimethyl-l-arginine in the plasma of patients with end-stage renal failure Nephrol. Dial. Transplant. 11 2449 2452
34. S. R. Gullans J. G. Verbalis 1993 Control of brain volume during hyperosmolar and hypoosmolar conditions Ann. Rev. Med. 44 289 301
35. R. O. Law 1994 Regulation of mammalian brain cell volume J. Exp. Zool. 268 90 96
36. H. Pasantes-Morales 1996 Volume regulation in brain cells: Cellular and molecular mechanisms Metab. Brain Dis. 11 187 204
37. B. Brahma R. E. Forman E. E. Stewart C. Nicholson M. E. Rice 2000 Ascorbate inhibits edema in brain slices J. Neurochem. 74 1263 1270
38. M. Zielinska R. O. Law J. Albrecht 2003 Excitotoxic mechanism of cell swelling in rat cerebral cortical slices treated acutely with ammonia Neurochem. Int. 43 299 303
39. M. K. Shih M. L. Hu 1999 UVA-induced oxidative damage to rat liver nuclei: reduction of iron ions and the relationship between lipid peroxidation and DNA damage Mutation Res. 438 125 132
40. N. D. Vaziri 2004 Oxidative stress in uraemia: Nature, mechanisms, and potential consequences Semin. Nephrol. 24 469 473
41. 35S]-t-butylbicyclophosphorothionate (TBPS) to rat brain synaptic membranes Neuropharmacol. 34 1607 161
42. N. Del Olmo J. Bustamante R. M. Del Rio J. M. Solis 2000 Taurine activates GABA A but not GABA B receptors in rat hippocampal CA1 area Brain Res. 864 298 307
43. B. Mayer 2000 Nitric oxide synthases catalyze superoxide formation FEBS Lett. 481 304
44. D. Stuehr S. Pou G. M. Rosen 2001 Oxygen reduction by nitric-oxide synthetase J. Biol. Chem. 276 14533 14536
45. A. Di Biasi R. Di Benedetto S. Salvati L. Attorri F. Leonardi D. Pietraforte 2005 Effects of L-mono methyl guanidine, N-acreyl arginine, and diphenyleniodonium on free radical release in C6 glial cells enriched in hexacosenoic acid Neurochem. Res. 30 215 223
46. D. Fliser 2005 Asymmetric dimethylarginine (ADMA): The silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule Eur. J. Clin. Invest. 35 71 79